CEL-SCI CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $15.9M | $18.2M | $22.5M | $25.4M | $23.1M | $17.8M | $12.7M | $10.9M |
| SG&A Expense | $8.9M | $8.2M | $9.0M | $10.7M | $13.1M | $11.7M | $8.0M | $6.3M |
| Operating Income | $-24.8M | $-26.4M | $-31.5M | $-36.1M | $-36.2M | $-29.0M | $-20.2M | $-16.8M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | $649.0K | $746.0K | $675.4K | $1.1M | — | $1.2M | — | — |
| Pretax Income | — | — | — | — | — | $-30.3M | $-22.1M | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-25.4M | $-26.9M | $-32.4M | $-36.7M | $-36.4M | $-30.3M | $-22.1M | $-31.8M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | $-0.44 | $-0.45 | $-0.41 | $-0.36 | $-0.94 |
| EPS (Diluted) | $-6.27 | $-7.66 | $-0.37 | $-0.44 | $-0.45 | $-0.41 | $-0.36 | $-0.94 |
| Shares Outstanding (Basic) | — | — | — | 86.3M | 81.3M | 73.5M | 62.3M | 34.0M |
| Shares Outstanding (Diluted) | 4.1M | 3.6M | 89.0M | 86.3M | 81.4M | 73.5M | 62.3M | 34.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |